BioXcel Therapeutics
BTAI
BTAI
94 hedge funds and large institutions have $167M invested in BioXcel Therapeutics in 2022 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 32 increasing their positions, 28 reducing their positions, and 16 closing their positions.
Holders
94
Holders Change
-2
Holders Change %
-2.08%
% of All Funds
1.59%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
15
Increased
32
Reduced
28
Closed
16
Calls
$2.11M
Puts
$1.68M
Net Calls
+$432K
Net Calls Change
+$1.37M
Top Buyers
1 |
1
Millennium Management
New York
|
$2.49M |
2 |
2
BlackRock
New York
|
$18.8M |
3 |
RCMNY
3
Rubric Capital Management (New York)
New York
|
$5.17M |
4 |
4
Voloridge Investment Management
Jupiter,
Florida
|
$1.35M |
5 |
![]()
5
Marshall Wace
London,
United Kingdom
|
$1.17M |